-
Italy blocks deliveries of AstraZeneca Covid vaccines
Vial of AstraZeneca vaccine against coronavirus (COVID-19) on the first day of a mass vaccination by police and fire departments at the Wanda Metropolitan Stadium. Marcos del Mazo | LightRocket | Getty Images LONDON – The European Union intervened in the supply of coronavirus vaccines for the first time. Italy blocked delivery of the AstraZeneca-Oxford…
-
Troops opting out of the Covid vaccine are “a part of the issue”.
A paratrooper assigned to the 82nd Airborne Division’s 1st Brigade Combat Team prepares for an airborne operation May 7 at Fort Bragg, NC. Spc. Hubert Delany III | US Army WASHINGTON – The White House Chief Medical Officer, Dr. Anthony Fauci said Thursday that U.S. service members who are eligible to receive the Covid-19 vaccine…
-
Texas governor Abbott blames Covid for the unfold of immigrants and criticizes Biden’s “Neanderthal” remark
Texas governor Greg Abbott Thursday criticized President Joe Biden for calling his decision to lift Covid-19 restrictions and masking mandates earlier this week “Neanderthal thinking,” making undocumented immigrants for the persistent Outbreak of the state responsible. Abbott’s comments come after its much-criticized decision on Tuesday to lift most of the state’s Covid-19 restrictions, including a…
-
Biden slams governors for lifting masks mandates, calling it “Neanderthal pondering”.
United States President Joe Biden speaks during a non-partisan meeting on cancer legislation in the Oval Office at the White House in Washington March 3, 2021. Alex Brandon | Pool | Reuters President Joe Biden on Wednesday beat up states that lifted Covid-19 restrictions on businesses and lifted mask mandates for local residents, calling the…
-
OSCR begins buying and selling on the NYSE
The New York Stock Exchange welcomes Oscar Health, Inc. (NYSE: OSCR) today, Wednesday, March 3, 2021, on the occasion of its initial public offering. NYSE Oscar Health shares closed 10.7% after going public on Wednesday. The stock began trading at $ 36 per share and closed at $ 34.80 on the New York Stock Exchange.…
-
5 issues it is best to know earlier than the inventory market opens on March third, 2021
Here are the top news, trends, and analysis investors need to get their trading day started: 1. Dow futures jump after early Tuesday profit bubbles and reverses Traders on the floor of the New York Stock Exchange Source: NYSE The Dow is set to rise 200 points on Wednesday after selling undone strong gains late…
-
Detroit Extends Covid Vaccine Eligibility to Auto Staff
Chrysler Jefferson North Assembly Plant in Detroit, Michigan Bill Pugliano | Getty Images DETROIT – production workers in the city, such as B. Auto workers, can now receive the Covid-19 vaccine without restrictions such as age or proof of pre-existing conditions. The expanded manufacturing worker eligibility in Detroit represents a significant expansion of the eligibility…
-
EU tries to rally help for unpopular AstraZeneca shot
French President Emmanuel Macron (L) takes photos with his smartphone from a document from German Chancellor Angela Merkel (R) during an EU summit in Brussels on July 20, 2020. JOHN THYS | AFP | Getty Images LONDON – European officials are coming under increasing pressure to lift restrictions on who can receive the AstraZeneca-Oxford coronavirus…
-
CDC director “actually involved” about states withdrawing Covid measures as instances seem to plateau
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention. Chip Somodevilla | Getty Images The head of the Centers for Disease Control and Prevention said Monday that she is “really concerned” that some states are pulling back public health measures to contain the coronavirus pandemic, as the US cases appear to be…
-
Novavax expects FDA approval in Might
The Food and Drug Administration could approve Novavax’s Covid-19 vaccine for emergencies as early as May, the company’s CEO Stanley Erck told CNBC on Monday. Novavax’s Phase 3 trial in the US with 30,000 participants is ongoing, Erck said. The company hopes the FDA will allow it to use data from its UK clinical trial…
